Ambev
ABEV

Ambev (ABEV) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
B of A SecuritiesDowngradedNeutral → Underperform$3.30Oct 7, 2026
ScotiabankDowngradedSector Outperform → Sector Perform—Jul 15, 2026
UBSMaintainedSell$2.90 from $2.65May 14, 2026
BarclaysMaintainedEqual-Weight$3.50 from $3.00May 6, 2026
UBSDowngradedNeutral → Sell—Apr 16, 2026
BarclaysMaintainedEqual-Weight$3.00 from $2.50Feb 17, 2026
BernsteinDowngradedOutperform → Market Perform$2.88Nov 26, 2025
UBSMaintainedNeutral$2.20 from $2.50Aug 20, 2025
HSBCDowngradedBuy → Hold—Aug 1, 2025
UBSMaintainedNeutral$2.70 from $2.60Jun 4, 2025
BarclaysMaintainedEqual-Weight$2.50 from $2.00May 12, 2025
UBSDowngradedBuy → Neutral—Apr 22, 2025
Morgan StanleyDowngradedEqual-Weight → Underweight—Apr 7, 2025
CitigroupDowngradedBuy → Neutral—Jan 22, 2025
BarclaysMaintainedEqual-Weight$2.00 from $2.50Jan 21, 2025
UBSMaintainedBuy$2.90 from $3.20Jul 31, 2024
BarclaysMaintainedEqual-Weight$2.50 from $3.00May 9, 2024
BarclaysDowngradedOverweight → Equal-Weight$3.00 from $3.50Mar 4, 2024
JefferiesInitiated CoverageHold$2.86Nov 22, 2023

Frequently asked questions

  • What is the latest analyst rating on ABEV?

    On Oct 7, 2026, B of A Securities downgraded Ambev to Underperform with a price target of $3.30.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.